(Health-NewsWire.Net, May 20, 2016 ) Publisher's, 'Chikungunya - Pipeline Review, H1 2016', provides an overview of the Chikungunya pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Chikungunya, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Chikungunya and features dormant and discontinued projects.
Publisher's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
Other Key Points in Report:
- The report provides a snapshot of the global therapeutic landscape of Chikungunya
- The report reviews pipeline therapeutics for Chikungunya by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Chikungunya therapeutics and enlists all their major and minor projects
- The report assesses Chikungunya therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
Inquire before Purchasing Report @ http://www.reportsweb.com/inquiry&RW0001239341/buying
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Chikungunya
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Chikungunya pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Ask for Sample Report @ http://www.reportsweb.com/inquiry&RW0001239341/sample
Table of Content: An Overview
Introduction 9
Publisher Report Coverage 9
Chikungunya Overview 10
Therapeutics Development 11
Pipeline Products for Chikungunya - Overview 11
Pipeline Products for Chikungunya - Comparative Analysis 12
Chikungunya - Therapeutics under Development by Companies 13
Chikungunya - Therapeutics under Investigation by Universities/Institutes 15
Chikungunya - Pipeline Products Glance 16
Clinical Stage Products 16
Early Stage Products 17
Chikungunya - Products under Development by Companies 18
Chikungunya - Products under Investigation by Universities/Institutes 19
Chikungunya - Companies Involved in Therapeutics Development 20
Abivax S.A. 20
Arbovax, Inc. 21
Arno Therapeutics, Inc. 22
Bharat Biotech International Limited 23
Etubics Corporation 24
Ask for Discount on Report @ http://www.reportsweb.com/inquiry&RW0001239341/discount
Indian Immunologicals Limited 25
Inovio Pharmaceuticals, Inc. 26
Integral Molecular, Inc. 27
Integrated BioTherapeutics, Inc. 28
Merck & Co., Inc. 29
Nanotherapeutics, Inc. 30
PaxVax, Inc. 31
Profectus BioSciences, Inc. 32
Takeda Pharmaceutical Company Limited 33
Themis Bioscience GmbH 34
Valneva SE 35
Chikungunya - Therapeutics Assessment 36
Assessment by Monotherapy Products 36
Assessment by Target 37
Assessment by Mechanism of Action 39
Assessment by Route of Administration 41
Assessment by Molecule Type 43
Drug Profiles 45
ABX-309 - Drug Profile 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
Antibody for Chikungunya - Drug Profile 46
Purchase Complete Report @ http://www.reportsweb.com/buy&RW0001239341/buy/2000
About Us:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Contact Us:
Email: sales@reportsweb.com
Call: +1-646-491-9876
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|